The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The G1660_SIGMA Drug Master File in Japan (G1660_SIGMA JDMF) empowers G1660_SIGMA API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the G1660_SIGMA JDMF during the approval evaluation for pharmaceutical products. At the time of G1660_SIGMA JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of G1660_SIGMA suppliers with JDMF on PharmaCompass.